Filter
660
Text search:
Antimicrobial
Therapy
Featured
Recommendations
100
New Publications
162
Language
Document type
No document type
274
Guidelines
161
Studies & Reports
129
Manuals
33
Strategic & Response Plan
27
Fact sheets
14
Training Material
10
Situation Updates
6
Online Courses
3
Infographics
2
Resource Platforms
1
Countries / Regions
India
40
South Africa
23
Global
20
Ethiopia
18
Africa
14
Uganda
11
Kenya
10
Western and Central Europe
10
Nigeria
9
Nepal
8
Eastern Europe
8
Tanzania
7
Indonesia
7
Latin America and the Carribbean
7
Asia
7
Russia
7
Zimbabwe
6
Philippines
6
Bangladesh
6
Sierra Leone
5
Ghana
5
Rwanda
5
Malawi
5
Liberia
4
Zambia
4
Namibia
4
Ukraine
4
Cameroon
3
Haiti
3
Eswatini/ Swaziland
3
East and Southern Africa
3
Western Pacific Region
3
Germany
2
Syria
2
Cambodia
2
Mozambique
2
Argentina
2
Brazil
2
North Macedonia
2
Lesotho
2
West and Central Africa
2
Georgia
2
Vietnam
2
Burkina Faso
1
Congo, Democratic Republic of
1
USA
1
Saudi Arabia
1
Somalia
1
Pakistan
1
South Sudan
1
Iraq
1
Jordan
1
Thailand
1
Serbia
1
Colombia
1
Ecuador
1
Angola
1
Myanmar / Burma
1
Sri Lanka
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Armenia
1
Laos
1
Timor Leste/ East Timor
1
Tajikistan
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
195
Clinical Guidelines
92
Women & Child Health
37
Public Health
23
Key Resources
16
Pharmacy & Technologies
14
Capacity Building
7
Annual Report MEDBOX
2
Toolboxes
AMR
172
TB
72
HIV
46
Pharmacy
39
COVID-19
33
Rapid Response
22
NTDs
20
Caregiver
17
Cholera
13
Ebola
11
Planetary Health
11
Global Health Education
8
NCDs
6
Health Financing Toolbox
5
Conflict
4
Refugee
4
Mental Health
4
Polio
3
Natural Hazards
3
Specific Hazards
3
Disability
2
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Brief instructions for the diagnostic of specimens coming from suspected plague cases and exposed contacts, including recommendations for diagnostic confirmation
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Sub-Saharan African Journal of Medicine: Year : 2014 | Volume : 1 | Issue : 1 | Page : 1-14
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three
...
The National Guidelines for HIV-1 Viral Load Laboratory Testing support plans to scale up viral load (VL) testing to reach the 90-90-90 targets in India. This phased scale-up includes the setup of 70 additional VL testing laboratories nationally. These guidelines include laboratory design considerat
...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg
...
National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
Cholera is an acute diarrhoeal disease caused by the ingestion of food or water contaminated with the bacterium V.
cholerae. It has a short incubation period of a few hours to 5 days. It is endemic in some countries, frequently
showing seasonal variations in the number of reported cases. Cholera a
...
It provides insight into WHO’s work that aims to improve the health of the people of the United Republic of Tanzania in collaboration with key stakeholders.
ECDC MISSION REPORT 19–21 September 2016 ; 14–15 November 2016
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
(Published with Decision No. 3003/QðBYT dated 19/8/2009 of the Minister of Health)
